GS-441524 injection is a specialized antiviral treatment developed for cats suffering from feline infectious peritonitis (FIP), a deadly and complex disease caused by a mutated feline coronavirus. The compound GS-441524 is a nucleoside analog that inhibits the replication of viral RNA, effectively targeting the root cause of the infection within the cat’s cells. This inhibition process helps reduce the spread of the virus throughout the cat’s body, providing a significant breakthrough for a disease that previously had limited treatment options.
The injectable form of GS-441524 is particularly beneficial for severe or advanced cases of FIP. Delivered subcutaneously, it ensures quick absorption into the bloodstream, allowing the medication to act rapidly, which is critical in acute cases where immediate intervention is necessary. The treatment regimen typically lasts 12 to 16 weeks, with the injection dose carefully adjusted based on the cat’s weight, the severity of the infection, and the type of FIP (either effusive or non-effusive). This method of administration is generally preferred when oral administration is less effective or when a cat’s symptoms require more intensive care.
While GS-441524 has shown impressive success rates, with many cats achieving remission, it is not yet FDA-approved. However, its efficacy in clinical trials and real-world cases has made it a key treatment option worldwide. The FDA’s recent decision to allow compounded GS-441524 under veterinary supervision has increased accessibility, providing more cats with potentially life-saving therapy. For veterinarians and cat owners, GS-441524 injection represents a major advancement, transforming FIP from an almost certain fatal diagnosis into a treatable condition. Its success has inspired ongoing research and clinical interest in antiviral therapies for animal diseases, opening new pathways for addressing complex viral infections in veterinary medicine.
| Product Name | GS-441524 |
| Expiry Date | 1 Year From The Date Of Manufacture |
| Storage Condition | Room Temperature |
| CAS | 1191237-69-0 |
| Function | Treatment For Cat FIP |
| Dosage Form | Injection |
| Country of Manufacture | China |
| Packaging | 6ml/vial, 8ml/vial, 10ml/vial |
| Strength | 20mg and 30mg |
GS-441524 is an antiviral drug that has shown promise in the treatment of feline infectious peritonitis (FIP), a viral disease caused by certain strains of feline coronavirus. As of my last update, GS-441524 is primarily used off-label in cats with FIP.
The dosage of GS-441524 injection for cats with FIP can vary depending on factors such as the cat's weight, the severity of the disease, and the veterinarian's assessment. Dosage regimens may also vary based on individual response and the specific formulation of GS-441524 being used.
Recommended dosage:
FIP(Wet): 0.3ml/kg * body weight kg + 0.1ml residue
FIP (Dry): 0.4ml/kg * body weight kg + 0.1ml residue
Eye / nerve entry: 0.5ml/kg * body weight kg + 0.1ml residue
Recurrence: 0.6 ml / kg * body weight kg + 0.1ml residue
